Search results
Author(s):
Charlotte Eitel
,
Gerhard Hindricks
,
Christopher Piorkowski
Added:
3 years ago
Cardiac resynchronisation therapy (CRT) is an established therapy for patients with drug-refractory, highly symptomatic systolic heart failure (HF) and delayed ventricular conduction.1 CRT devices are designed to synchronise the mechanical activity within the left ventricle, between the left and the right ventricle and between the atria and ventricles. Resynchronisation induces reverse…
View more
Author(s):
Patrick Wong
,
Umair Shafique
Added:
3 years ago
Cardiovascular (CV) events are a major cause of mortality worldwide1 that are often precipitated by acute coronary syndromes (ACS). ACS result from the acute obstruction of coronary arteries and are defined as either unstable angina (UA) or myocardial infarction (MI), with or without ST-segment-elevation (STEMI and NSTEMI, respectively). Patients with moderate- to high-risk ACS are managed by an…
View more
Author(s):
Franz-Josef Neumann
Added:
3 years ago
Acute coronary syndromes (ACS) have been associated with the occurrence of cardiovascular (CV) events. Moderate- to high-risk ACS are generally managed by an early invasive approach, where coronary angiography is followed by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). However, ACS and the use of PCI or CABG are associated with a high risk of thrombotic…
View more
Added:
5 years ago
BAROSTIM THERAPY for RHTN Physician Testimonial
View more
Author(s):
William Foster
,
Mark Sopher
Added:
3 years ago
In 1966, following the death of his mentor Professor Harry Heller from ventricular tachycardia (VT), Michel Mirowski began to research a way to prevent future deaths from ventricular arrhythmia, working with Morton Mower and William Staewen in Sinai Hospital, Baltimore. The first human implant of an automated implanted cardioverter defibrillator (ICD) took place in 1980 amid much criticism and…
View more
Author(s):
Sasha Koul
,
David Erlinge
Added:
3 years ago
Acute coronary syndromes (ACS) are a major reason for death and morbidity in the industrialised world. One of the most successful treatments for ACS has been strategies to target the platelets and inhibit their function.
Mechanisms of Platelet Activation
Thrombus formation in the arteries is dependent on platelets and their ability to attach to the injured wall despite the rapid arterial blood…
View more
Author(s):
Alessandro Marinelli
,
Mario Luzi
,
Alessandro Capucci
Added:
3 years ago
Several randomised controlled trials (RCTs) have proven the efficacy of the implantable cardioverter-defibrillator (ICD) in preventing sudden cardiac death (SCD) in patients with advanced systolic heart failure (HF) and reduced left ventricular ejection fraction (LVEF).1–3 ICD therapy proved to be efficacious also in other conditions at high risk for arrhythmic death such as familial SCD…
View more
Author(s):
Ralf Stewart
Added:
4 years ago
Dr Ralph Stewart (Auckland City Hospital, Auckland, NZ) provides a comprehensive overview of the New Zealand oxygen therapy in acute coronary syndromes (NZOTACS) trial.
Questions
1. What does NZOTACS aim to address?
2. What is the study design, inclusion criteria, and end points?
3. What were your findings?
4. How does this data compare to DETO2X-AMI?
Filmed on site at ESC 2019 by…
View more
Author(s):
Michel Burnier
Added:
3 years ago
In 2007, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) published their guidelines for the management of arterial hypertension.1 These guidelines covered in detail all aspects of the management of hypertensive patients, from the diagnosis and detection of early subclinical organ damage to the discussion of the various therapeutic strategies in essential…
View more